Skip to content

Comparing Chlorhexidine Gel and a Gel with Both Chlorhexidine and Metronidazole for Treating Long-lasting Gum Disease.

Comparative Evaluation of Chlorhexidine Gel alone and a Combination Gel Chlorhexidine and Metronidazole in treatment of Chronic Periodontitis - nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080462
Enrollment
30
Registered
2025-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Combination gel (Chlorhexidine + metronidazole).: Scaling and root planing + local drug delivery (Chlorhexidine + metronidazole gel). dosage is once, Local application of gel for one da

Sponsors

Dr Saheli Paul
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of chronic periodontitis having bilateral periodontal pocket of probing depth 4mm-5mm. Both sexes are included. An age group of 20-50 years will be taken.

Exclusion criteria

Exclusion criteria: Patients who have already received periodontal therapy in past 1 year. Pregnant women & lactating mothers. Women using hormonal contraceptives or on hormonal replacement therapy. Patients having habit of smoking or chewing tobacco. Patients allergic to either Chlorhexidine or Metronidazole. Patients having any known systemic conditions:- Diabetes, Hypertension, Thyroid disorders, or any other condition affecting periodontal status.

Design outcomes

Primary

MeasureTime frame
Recording reduction of Relative attachment level using Stent.Timepoint: 0-30 Days

Secondary

MeasureTime frame
Gingival Index, Plaque Index, Pocket probing depth.Timepoint: 0-30 Days

Countries

India

Contacts

Public ContactDr Saheli Paul

Army College of Dental Sciences

reddyajay56@yahoo.in9618321234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026